News

Ablaze Pharma Aligned The Strategic Agreement With Wenjiang District Government of Chengdu to Build-up the Innovative R&D and Manufacturing Center for Targeted Radiopharmaceutical Therapies

2022-8-05

Novaremed enters into an exclusive option and license agreement with NeuroFront for the non-opioid neuropathic pain treatment, NRD.E1, for Greater China and Singapore

2022-7-21

Plexium Announces $102m Financing to Advance Pipeline of Targeted Protein Degradation Therapies and Technology Platform

2022-2-23

OncXerna is selected as Global Top 5 Precision Medicine Startups

2022-2-17

Exact Sciences and OncXerna Announce Licensing Agreement to Help Predict Immunotherapy Response for More Patients

2022-1-10

Pivotal bioVenture Partners China Announces Formation of SanReno Therapeutics

2021-12-03

Ablaze Pharmaceuticals Launches with $75m Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market

2021-11-29

Zenas BioPharma Acquires Exclusive Worldwide Rights to Obexelimab from Xencor

2021-11-23

Arctic Vision’s Collaboration Partner, Clearside Biomedical Inc., Has Obtained U.S. FDA Approval of XIPERE™ (ARVN001) for Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis

2021-10-26

Arctic Vision Obtains China IND Clearance for Phase III Study of ARVN003, the First in China for Presbyopia Treatment

2021-9-03

Arctic Vision Announces Expansion of License Territory for Suprachoroidal Space Injection Therapy ARVN001 to Include ASEAN Countries and India

2021-8-15

QIAGEN and OncXerna Therapeutics Sign Licensing and Master Companion Diagnostic Agreements

2021-8-09

Engrail Therapeutics Extends Series A Financing to $64 Million

2021-8-03

Arctic Vision Received China IND Clearance for Phase III Study of ARVN002 to Reduce Paediatric Myopia Progression

2021-8-02

NeuroFront Announces Exclusive Licensing Agreement for Development and Commercialization of Neurolief’s Relivion® in Greater China and South Korea

2021-7-09

Exscientia announces investment of up to $525M

2021-4-26

Evommune完成1250万美元种子轮融资

2020-11-20

Oncologie（鼎航医药）公布最新临床研究数据

2020-9-21

Arctic Vision Announces US$32MN in Series A

2020-7-14

Oncologie Launches with 16.5M USD Seed Funding Led by Pivotal bioVenture Partners China

2018-6-07

Pivotal bioVenture Partners China Closes Inaugural $150 Million Early Stage VC Fund

2018-5-24